Kuang-Chi Technologies (002625) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
25 Aug, 2026Executive summary
Revenue for H1 2026 reached ¥1.13 billion, up 19.59% year-over-year, driven by increased sales of advanced metamaterial products and expanded commercial contracts.
Net profit attributable to shareholders was ¥318.82 million, down 17.35% year-over-year, mainly due to higher R&D and management expenses and increased credit impairment losses.
The company maintained its position as the only large-scale producer of metamaterial applications in China, with significant advances in AI-driven design, micro-nano manufacturing, and composite materials.
Major contracts signed by subsidiaries totaled over ¥875 million, with deliveries scheduled through 2027.
Financial highlights
Operating income: ¥1,127,996,918.41, up 19.59% year-over-year.
Net profit attributable to shareholders: ¥318,817,085.20, down 17.35% year-over-year.
Operating cash flow: ¥166,610,480.56, up 3.35% year-over-year.
Gross margin for main business: 50.29%, down 4.76 percentage points year-over-year.
R&D investment: ¥79,494,391.70, up 19.01% year-over-year.
Basic and diluted EPS: ¥0.15, down from ¥0.18 year-over-year.
Outlook and guidance
The company expects continued growth in metamaterial product demand, with a robust order backlog and new contracts supporting future revenue.
Strategic focus remains on high-end equipment, AI-driven innovation, and expanding commercial applications.
Adjustments to employee incentive targets reflect updated delivery schedules and business realities.
Latest events from Kuang-Chi Technologies
- Revenue and net profit rose strongly, but operating cash flow fell sharply amid major new contracts.002625
Q1 2026 - Revenue up 31%, net profit up 5%, strong cash flow and major new contracts boost growth.002625
Q4 2025 - Strong revenue and profit growth supported by major new contracts and robust demand.002625
Q3 2025 - Revenue and net profit rose, with strong margins and major new contracts signed.002625
Q2 2025 - Net profit rose 19.48% year-over-year in Q3 2024, driven by robust metamaterials growth.002625
Q3 2024 - Net profit rose 20.33% year-over-year on stable revenue and strong contract wins.002625
Q2 2024 - Net profit rose 11.77% to ¥652 million on 4.25% revenue growth, with strong R&D gains.002625
Q4 2024 - Revenue and profit grew solidly in Q1 2025, driven by new metamaterial contracts.002625
Q1 2025